StrandID is building the universal detection engine for point-of-care diagnostics. Our mission is to transform disease detection by making advanced diagnostics accessible, affordable, and immediate, enabling earlier intervention and better outcomes for patients worldwide.

Our platform, STRAND, uses computationally designed DNA probes that bind cooperatively across pathogen genomes, achieving molecular-level sensitivity in a simple, equipment-free format. No PCR machines, no trained technicians, no lab infrastructure. Just add a sample lysate and read the result.

We believe that timely information saves lives, and that sophisticated diagnostics shouldn't require sophisticated infrastructure. By engineering elegant solutions from first principles, we work to ensure that geography and resources never determine who gets diagnosed in time.

We partner with diagnostics companies, kit manufacturers, and global health organizations to embed STRAND detection into their testing workflows. Partners bring the sample preparation; we provide a single, scalable detection device that can be rapidly configured for any sequenced pathogen (bacteria, fungi, parasites) or biological state by swapping out probe sets designed by our open-source computational pipeline. One platform, unlimited targets, deployed everywhere from rural clinics to emergency field operations.

Our science is rigorous. Our tools are built for the real world, for real people, in real conditions. StrandID is based in Menlo Park, CA and spun out of research at Stanford University.

StrandID

Org chart

Teams

Offices

StrandID

Org chart

Teams

Offices

Related companies